HIGH

CORNEAT VISION Recalls EverPatch+ Due to Conjunctival Wound Risk

CORNEAT VISION recalled 180 units of EverPatch+ on August 18, 2025, due to a risk of conjunctival wound dehiscence. This defect may lead to early exposure of the surgical patch. The recall affects distribution across the United States and several countries.

Quick Facts at a Glance

Recall Date
August 18, 2025
Hazard Level
HIGH
Brand
CORNEAT VISION
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact CORNEAT VISION, LTD. or your healthcare provider for instructions. Notification method: E-Mail

Product Details

The recalled product is EverPatch+, REF: 1044002, with a permanent scleral reinforcement matrix measuring 1x5.0mm x 8.5 mm for the shield and 1 x 5.0mm x 6.5 mm for the rectangle. The product was distributed worldwide, including states across the U.S. and countries like Japan and Israel.

The Hazard

Complaints indicate that conjunctival wound dehiscence may result in early exposure of the surgical patch. This condition poses a significant risk to patients undergoing surgical procedures.

Reported Incidents

Currently, there are no specific reported incidents associated with injuries or fatalities from this recall. The potential risk is classified as high.

What to Do

Patients and healthcare providers should immediately stop using the EverPatch+. Follow the recall instructions from CORNEAT VISION, LTD. For guidance, contact the manufacturer or your healthcare provider.

Contact Information

For more information, contact CORNEAT VISION, LTD. via email. Details can be found on the FDA recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0040-2026.

Key Facts

  • Recall date: August 18, 2025
  • Quantity recalled: 180 units
  • Hazard level: High
  • Distribution: Worldwide, including U.S. states and Japan
  • Classification: Class II

Get Alerts for Health & Personal Care Recalls

Get notified about recalls in categories you care about.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeScleral Reinforcement Matrix
Sold At
Multiple Retailers

Product Details

Model Numbers
All Lots/ UDI: G16010440020
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more